BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26872765)

  • 1. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Wu GX; Goldstein L; Kim JY; Raz DJ
    Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
    Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
    Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of NLST screening criteria in Asian lung cancer patients.
    Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
    BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
    Landy R; Cheung LC; Young CD; Chaturvedi AK; Katki HA
    Cancer; 2024 Jan; 130(2):201-215. PubMed ID: 37909885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
    Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
    Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
    McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
    J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital.
    Liu A; Siddiqi N; Tapan U; Mak KS; Steiling KA; Suzuki K
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):2836-2843. PubMed ID: 36441493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial.
    Gerber DE; Hamann HA; Santini NO; Abbara S; Chiu H; McGuire M; Quirk L; Zhu H; Lee SJC
    Contemp Clin Trials; 2017 Sep; 60():78-85. PubMed ID: 28689056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
    Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
    Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Cancer Society lung cancer screening guidelines.
    Wender R; Fontham ET; Barrera E; Colditz GA; Church TR; Ettinger DS; Etzioni R; Flowers CR; Gazelle GS; Kelsey DK; LaMonte SJ; Michaelson JS; Oeffinger KC; Shih YC; Sullivan DC; Travis W; Walter L; Wolf AM; Brawley OW; Smith RA
    CA Cancer J Clin; 2013; 63(2):107-17. PubMed ID: 23315954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Smokers' Preferences for Receiving Cessation Information in a Lung Cancer Screening Setting.
    Carter-Harris L; Schwindt R; Bakoyannis G; Ceppa DP; Rawl SM
    J Cancer Educ; 2018 Oct; 33(5):1120-1125. PubMed ID: 28405898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT Lung Screening in Patients with Laryngeal Cancer.
    Piersiala K; Akst LM; Hillel AT; Best SR
    Sci Rep; 2020 Mar; 10(1):4676. PubMed ID: 32170175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States.
    Cao P; Jeon J; Levy DT; Jayasekera JC; Cadham CJ; Mandelblatt JS; Taylor KL; Meza R
    J Thorac Oncol; 2020 Jul; 15(7):1160-1169. PubMed ID: 32160967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
    Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
    JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility for screening with low-dose CT in a real-world cohort of patients with lung cancer in Greece: A brief report.
    Livanou ME; Syrigos NK; Montgomery A; Moeckel C; Panagiotou E; Charpidou A; Mouratidis I; Georgakopoulos-Soares I; Vathiotis IA
    Lung Cancer; 2023 Dec; 186():107424. PubMed ID: 37979487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Singapore lung cancer patients who miss out on lung cancer screening recommendations.
    Loh CH; Koh PW; Ang DJM; Lee WC; Chew WM; Koh JMK
    Singapore Med J; 2024 May; 65(5):279-287. PubMed ID: 35366661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Lung Cancer Screening Guideline.
    Senthil P; Kuhan S; Potter AL; Jeffrey Yang CF
    Thorac Surg Clin; 2023 Nov; 33(4):323-331. PubMed ID: 37806735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    Pelosof L; Ahn C; Gao A; Horn L; Madrigales A; Cox J; McGavic D; Minna JD; Gazdar AF; Schiller J
    J Natl Cancer Inst; 2017 Jan; 109(7):. PubMed ID: 28132018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened.
    Gieske MR; Kerns J; Schmitt GM; Kloecker G; Budhani IA; Nolan J; Williams VA; Alkapalan D; Ferguson K; Yadav R; Calhoun RF
    J Med Screen; 2024 Jun; 31(2):99-106. PubMed ID: 37855047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess pancreatic cancer risk due to smoking and modifying effect of quitting smoking: The Multiethnic Cohort Study.
    Bogumil D; Stram D; Preston DL; Pandol SJ; Wu AH; McKean-Cowdin R; Conti DV; Setiawan VW
    Cancer Causes Control; 2024 Mar; 35(3):541-548. PubMed ID: 37924460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.